Application of Second Generation Tyrosine Kinase Inhibitors in BCR-ABL Positive Malignancies in the Post-Transplant Period
E. Klyuchnikov, O. Osanmaz, P. Schafhausen, S. Asenova, T. Zabelina, F. Ayuk, T. Bruemmendorf, A.R. Zander, N. Kroeger, U. BacherVolume:
15
Year:
2009
Language:
english
DOI:
10.1016/j.bbmt.2008.12.310
File:
PDF, 54 KB
english, 2009